A Randomized Clinical Trial to Measure the Effect of Pioglitazone on Insulin Sensitivity in Healthy Overweight and Obese Males
Phase of Trial: Phase I
Latest Information Update: 25 Nov 2015
At a glance
- Drugs Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Merck Sharp & Dohme
- 12 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 06 May 2010 New trial record